Aion Therapeutic Inc. News Releases

Aion Therapeutic Announces Change of Auditor

Fri, 06 Jun 2025 17:38:00 -0400

Toronto, Ontario--(Newsfile Corp. - June 6, 2025) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that the Company's audit committee and board of directors approved a change in the Company's auditors from DNTW Toronto LLP (the "Former Auditor") to Horizon Assurance LLP (the "Successor Auditor"), effective June 6, 2025.There were no reservations in the Former Auditor's reports for the two most recently completed fiscal years or for any period after the...

Aion Therapeutic Provides Update on Non-Brokered Private Placement Offering of Units

Fri, 06 Dec 2024 17:30:00 -0500

Toronto, Ontario--(Newsfile Corp. - December 6, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") provides an update on its previously announced private placement. Further to the news release dated October 21, 2024, the Company intends to complete a non-brokered private placement offering (the "Offering") of up to 33,333,333 units ("Units"), at a price of $0.015 per Unit, for total gross proceeds of up to approximately $500,000. The Company anticipates that the...

Aion Therapeutic Announces Revocation of MCTO

Wed, 13 Nov 2024 18:48:00 -0500

Toronto, Ontario--(Newsfile Corp. - November 13, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that it has received an order from the British Columbia Securities Commission (the "BCSC") revoking the management cease trade order (the "MCTO") previously granted by the BCSC on August 29, 2024.As previously announced, the MCTO was granted by the BCSC at the Company's request on August 29, 2024, due to delays in filing the Company's annual...

Aion Therapeutic Provides Bi-Weekly MCTO Status Update

Thu, 24 Oct 2024 17:00:00 -0400

Toronto, Ontario--(Newsfile Corp. - October 24, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is providing this bi-weekly update on the status of its management cease trade order issued on August 29, 2024 (the "MCTO"), by its principal regulator, the British Columbia Securities Commission (the "BCSC"), under National Policy 12-203 Management Cease Trade Orders ("NP 12-203"). The Company announced on August 14, 2024 (the "Default Announcement"), that it expected...

Aion Therapeutic Hires CRO for Toppen Health; Announces Director Resignation

Wed, 23 Oct 2024 07:55:00 -0400

Toronto, Ontario--(Newsfile Corp. - October 23, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company"), through its water filtration subsidiary, Toppen Health, Inc. ("Toppen" or "Toppen Health"), is excited to announce the appointment of Charles Freihofer as its new Chief Revenue Officer ("CRO"). Mr. Freihofer joined Toppen in mid-September to lead the organization's renewed focus on revenue and earnings. The Company is also announcing that Larry Horwitz resigned as a...

Aion Therapeutic Announces Non- Brokered Private Placement Offering of Units

Mon, 21 Oct 2024 17:54:00 -0400

Toronto, Ontario--(Newsfile Corp. - October 21, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that it intends to complete a non-brokered private placement offering (the "Offering") of up to 33,333,333 units ("Units"), at a price of $0.015 per Unit, for total gross proceeds of up to approximately $500,000.Each Unit will consist of one common share ("Share") and one half of one common share purchase warrant ("Warrant"). Each full Warrant...

Aion Therapeutic Provides Bi-Weekly MCTO Status Update

Thu, 10 Oct 2024 16:15:00 -0400

Toronto, Ontario--(Newsfile Corp. - October 10, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is providing this bi-weekly update on the status of its management cease trade order issued on August 29, 2024 (the "MCTO"), by its principal regulator, the British Columbia Securities Commission (the "BCSC"), under National Policy 12-203 Management Cease Trade Orders ("NP 12-203"). The Company announced on August 14, 2024 (the "Default Announcement"), that it expected...

Aion Donates Toppen Water Filtration Solutions to Support Hurricane Helene Relief Efforts

Thu, 10 Oct 2024 07:50:00 -0400

Sandford, Florida--(Newsfile Corp. - October 10, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company"), through its water filtration subsidiary, Toppen Health, Inc. ("Toppen" or "Toppen Health"), announced today that it has donated multiple water filtration systems to Trinity Baptist Church to support Hurricane Helene recovery and relief efforts in western North Carolina.Labeled one of the most deadly hurricanes to hit the United States mainland in over 50 years,...

Aion Announces CSA Certification for Toppen Water Filtration Solutions

Tue, 08 Oct 2024 07:50:00 -0400

Toronto, Ontario--(Newsfile Corp. - October 8, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company"), through its water filtration subsidiary, Toppen Health, Inc. ("Toppen" or "Toppen Health"), is excited to announce that as of September 26, 2024, certain models of its water filtration solutions have received the Canadian Standards Association ("CSA") Group certification of "Class 6811 43 PLUMBING - DRINKING WATER TREATMENT SYSTEMS - Certified to CSA B483.1."CSA...

Aion Therapeutic Provides Bi-Weekly MCTO Status Update

Thu, 26 Sep 2024 17:12:00 -0400

Toronto, Ontario--(Newsfile Corp. - September 26, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is providing this bi-weekly update on the status of its management cease trade order issued on August 29, 2024 (the "MCTO"), by its principal regulator, the British Columbia Securities Commission (the "BCSC"), under National Policy 12-203 Management Cease Trade Orders ("NP 12-203"). The Company announced on August 14, 2024 (the "Default Announcement"), that it...